OBJECTIVE: Quantitative analysis of real-world coverage decision-making offers insights
into the revealed preferences of appraisal committees. Aim of this review was to structure …

Introduction: Although pharmaceutical companies, regulatory authorities, and health
technology assessment (HTA) agencies have been increasingly using decision-making …

Background Most orphan drugs do not meet traditional standards of cost-effectiveness. Yet,
most orphan drugs are reimbursed, which implies that other factors are taken into account at …

Background Decision-making in healthcare is complex. Research on coverage decision-
making has focused on comparative studies for several countries, statistical analyses for …

The aim of this study was to analyze influences of process-and technology-related
characteristics on the outcomes of coverage decisions. Using survey data on 77 decisions …

Objectives: The role and impact of health technology assessment (HTA) in health policy has
been widely discussed. Researchers have started to analyze how decisions on coverage of …

Decision-makers need to make choices to improve public health. Population-based
newborn screening (NBS) is considered as one strategy to prevent adverse health outcomes …

Third party payers' decision processes for financing health technologies ('fourth
hurdle'processes) are subject to intensive descriptive empirical investigation. This paper …

Background. To achieve fair-coverage decision making, both material criteria and criteria of
procedural justice have been proposed. The relationship between these is still unclear …

Das achte Kapitel widmet sich den folgenden Fragen:(Wie) kann für das Produkt die
Erstattung durch Kostenträger erreicht werden? Welche Wege in die Vergütung gibt es bzw …